bbo-8520
·Code: BBO-8520
bbo-8520: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | Phase 1 |
Clinical Trials (1)
A Phase 1a/1b Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of BBO-8520 in Subjects With Advanced KRASG12C Mutant Non-Small Cell Lung Cancer - The ONKORAS-101 Study
Frequently asked questions
Who is developing bbo-8520?
bbo-8520 is being developed by BridgeBio Oncology Therapeutics, Inc..
How many clinical trials involve bbo-8520?
BioSniper tracks 1 clinical trial involving bbo-8520.
Get deeper analysis on bbo-8520
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis